IRIS
PIERONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.029
AS - Asia 3.045
EU - Europa 1.934
SA - Sud America 477
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 168
OC - Oceania 7
Totale 9.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.900
SG - Singapore 1.023
CN - Cina 781
VN - Vietnam 519
IT - Italia 468
BR - Brasile 357
IE - Irlanda 300
SE - Svezia 252
HK - Hong Kong 229
DE - Germania 174
FI - Finlandia 152
TR - Turchia 114
FR - Francia 108
ZA - Sudafrica 107
NL - Olanda 97
GB - Regno Unito 89
IN - India 66
RU - Federazione Russa 66
CA - Canada 57
AT - Austria 51
BD - Bangladesh 47
AR - Argentina 44
KR - Corea 40
CI - Costa d'Avorio 29
ES - Italia 28
IQ - Iraq 28
MX - Messico 28
ID - Indonesia 27
JP - Giappone 26
BE - Belgio 25
PL - Polonia 25
PK - Pakistan 23
CO - Colombia 21
PH - Filippine 21
CZ - Repubblica Ceca 19
SA - Arabia Saudita 16
VE - Venezuela 16
UA - Ucraina 15
EC - Ecuador 14
MA - Marocco 13
LT - Lituania 12
LU - Lussemburgo 12
GH - Ghana 11
UZ - Uzbekistan 11
CR - Costa Rica 9
MY - Malesia 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
EG - Egitto 7
IL - Israele 7
TW - Taiwan 7
BO - Bolivia 6
KZ - Kazakistan 6
PY - Paraguay 6
AL - Albania 5
AU - Australia 5
AZ - Azerbaigian 5
HN - Honduras 5
JM - Giamaica 5
KG - Kirghizistan 5
SV - El Salvador 5
TN - Tunisia 5
CH - Svizzera 4
DZ - Algeria 4
GT - Guatemala 4
LV - Lettonia 4
PA - Panama 4
PE - Perù 4
SN - Senegal 4
NI - Nicaragua 3
NP - Nepal 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
CY - Cipro 2
EE - Estonia 2
GP - Guadalupe 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
MD - Moldavia 2
MM - Myanmar 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
GE - Georgia 1
Totale 9.664
Salva come PNG Salva come JPEG
Città #
Ashburn 594
Singapore 558
San Jose 383
Chandler 339
Dublin 296
Santa Clara 272
Dallas 263
Hong Kong 212
Beijing 167
Ho Chi Minh City 158
Ann Arbor 146
Council Bluffs 125
Parma 125
Hanoi 118
Johannesburg 99
Boardman 97
Los Angeles 97
Shanghai 77
Izmir 73
Dearborn 72
Munich 63
New York 63
Lauterbourg 62
Nanjing 62
Hefei 59
Princeton 58
Helsinki 55
Washington 55
Columbus 47
Wilmington 43
Bremen 40
Bologna 37
Vienna 37
Chicago 35
São Paulo 35
Moscow 32
Buffalo 30
Turku 30
Abidjan 29
The Dalles 28
Hillsboro 27
Atlanta 25
Milan 25
Frankfurt am Main 24
Guangzhou 24
Seoul 23
Haiphong 22
London 22
Kocaeli 21
Warsaw 21
Da Nang 20
Jakarta 19
Brooklyn 18
Houston 18
San Mateo 18
Seattle 18
Shenyang 18
Tokyo 18
Brussels 17
Nanchang 17
Falls Church 16
Hebei 16
Chennai 15
Brasília 14
Changsha 14
Phoenix 14
Jinan 13
Orem 13
Brno 12
Jiaxing 12
Montreal 12
Norwalk 12
Curitiba 11
Rome 11
Toronto 11
Amsterdam 10
Baghdad 10
Kyiv 10
North Bergen 10
Nuremberg 10
Accra 9
Istanbul 9
Modena 9
San José 9
Verona 9
Bogotá 8
Denver 8
Des Moines 8
Fremont 8
Luxembourg 8
Manchester 8
Porto Alegre 8
Rio de Janeiro 8
Bengaluru 7
Cairo 7
Caracas 7
Edinburgh 7
Florence 7
Las Vegas 7
Naples 7
Totale 5.990
Salva come PNG Salva come JPEG
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 281
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 228
Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor 218
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 215
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 205
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 204
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 202
Nuovi composti antimicrobici 200
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 195
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 189
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 186
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 185
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 184
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 181
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 179
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 174
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 173
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 173
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 170
Antituberculosis agents: Beyond medicinal chemistry rules 166
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 165
Towards the sustainable discovery and development of new antibiotics 162
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 158
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 157
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 153
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 153
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 152
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 152
Quorum sensing inhibitors (QSIs): a patent review (2019–2023) 150
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 150
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 149
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 147
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 141
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 140
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 140
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 140
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 138
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 136
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 135
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 134
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 131
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 129
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 128
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 127
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 124
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 121
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 119
Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes 118
Benzotriazole derivatives as alternate O-acetylserine sulfhydrylase substrates to impair cysteine biosynthesis in Gram-negative bacteria 112
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 110
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 106
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 102
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 102
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 99
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 96
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 94
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype 93
Indoleamides are active against drug-resistant mycobacterium tuberculosis 93
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 92
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 89
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 88
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 81
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 81
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 79
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 78
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 77
Spectinamides: A challenge, a proof, and a suggestion 75
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 74
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 72
Gaining insights into MmpL3: combining structural and computational approaches to unlock transport and inhibitor-binding mechanisms 45
Serine Acetyltransferase from Pseudomonas aeruginosa: Distinctive Features, Pleiotropic Roles, and Therapeutic Potential 30
Antibacterial and antibiofilm activity of a triterpenoid-rich Eucalyptus globulus leaf extract against gram-positive bacteria 20
Totale 9.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.706
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022311 0 0 0 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/20251.751 64 90 144 95 151 221 109 69 155 163 195 295
2025/20264.080 414 357 554 359 563 225 448 157 470 291 154 88
2026/2027855 76 164 204 411 0 0 0 0 0 0 0 0
Totale 9.845